Creon
- Product NDC
- 0032-2636
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pancrelipase
- Dosage form
- CAPSULE, DELAYED RELEASE PELLETS
- Route
- ORAL
- Labeler
- AbbVie Inc.
- Application
- BLA020725
- Marketing category
- BLA
- Substance
- PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 0032-2636-01 | 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-01) | 2023-10-12 | | No | Historical |
| 0032-2636-30 | 24 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-30) | 2023-10-12 | | Yes | Historical |
| 0032-2636-70 | 240 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-2636-70) | 2023-10-12 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Creon | AbbVie Inc. | 2024-02-28 | HUMAN PRESCRIPTION DRUG LABEL | 108 |